Penn State researcher Steven Schiff was awarded an $8.1 million National Institutes of Health (NIH) High-Risk, High Reward grant. His vision for new predictive models may transform personalized treatment of infectious disease in the developing world. Infections are the most common cause for hydrocephalus in newborns and children in these countries. Being able to prevent infections will help to reduce the risk of post-infectious hydrocephalus.
Pierre Mertens and Lieven Bauwens met with Steven Schiff in Delft late september 2018 for a research project on low-cost MRI. That project aims to deliver low cost, sustainable medical imaging to our projects in Uganda. On the photo the group of Delft and Leiden on the front right Steven Schiff.